Drugs / Rotavirus
Rotavirus
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05155579 | May 2022 → May 2025 | malaria | University of Oxford | Completed | No outcome recorded |
| Phase 34 trials | ||||||
| Phase 3 | NCT00474526 | Mar 2007 → Sep 2008 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
| Phase 3 | NCT00140686 | Sep 2004 → Aug 2006 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00197210 | Dec 2003 → Jul 2007 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00140673 | Aug 2003 → Oct 2005 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06038617 | Oct 2023 → Apr 2025 | — | Duke University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03180359 | Jan 2016 → Oct 2019 | disease related to transplantation | Hospices Civils de Lyon | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02174705 Comparator | Jun 2014 → Sep 2015 | — | Anna Taddio | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rotavirus | “Pneumococcal, DTaP, Haemophilus Influenzae Type B, MMR, Varicella, MMRV, Hepatitis A, Inactivated Poliovirus, Hepatitis B, Rotavirus, Influenza vaccines” NCT06038617 ↗ |
| Known as | HRV | “GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine” NCT00140673 ↗1“Human Rotavirus (HRV) Vaccine” NCT00140686 ↗ |
| Known as | RotaTeq Rotavirus Vaccine, Live, Oral, Pentavalent | “RotaTeq® Rotavirus Vaccine, Live, Oral, Pentavalent” NCT00474526 ↗ |
| Modality | Vaccine | “HRV Vaccine” NCT00140673 ↗ |
| Route | Oral | “Two oral doses administered to healthy infants” NCT00140673 ↗ |